Skip to content

Clinical Use of a New Neonatal MRI System

Clinical Use of a New Neonatal MRI System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01801865
Enrollment
657
Registered
2013-03-01
Start date
2012-04-30
Completion date
2018-03-31
Last updated
2020-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnetic Resonance Imaging

Keywords

NICU, MRI, Neonatal

Brief summary

The purpose of the present study is to make medically indicated state of the art/high end magnetic resonance imaging (MRI) exams available to all infants in the Cincinnati Children's Hospital Medical Center (CCHMC) Neonatal Intensive Care Unit (NICU).

Detailed description

The current practice of transferring infants from the Neonatal Intensive Care Unit (NICU) to radiology departments and imaging in adult-sized magnetic resonance imaging (MRI) scanners is associated with significant safety and image quality issues. For these reasons, the smallest and/or sickest neonates are typically precluded from receiving an MRI exam. The overreaching goal of our research effort is to bring high-performance MRI into the NICU so that all neonates can benefit from the same quality of diagnostic imaging as adults. To accomplish this, we have converted a commercial small-bore 1.5 Tesla (T) MRI scanner designed for orthopedic use into a neonatal MRI system optimized for whole body imaging of neonates. To expand the imaging capabilities of the NICU MRI system, the measurement control electronics and operating system software of the FDA cleared imaging OPTIMA platform have been augmented with state of the art HDX electronics and software currently used on a conventional commercially available adult sized whole body MRI scanner. The clinical safety of the integrated HDX/OPTIMA NICU MRI system and its ability to produce diagnostic image quality has been shown in 15 pilot patients (CCHMC Protocol 2011-2045). The present protocol builds and expands upon the previous to use the integrated NICU MRI system to perform MRI exams in the neonatal population.

Interventions

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Any infant admitted to the NICU at CCHMC * Have a medical condition for which an MRI exam is indicated, as determined by the attending neonatologist * Able to maintain body temperature for at least 90 minutes without the aid of an incubator or radiant warmer int he opinion of the attending neonatologist * Parental/LAR permission obtained

Exclusion criteria

* Infants too large to fit in the customized NICU MRI system comfortably (expected to be infants heavier than 6 kg) * Standard MRI

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Adverse Events as Observed During and After Scanning.Day 1Any observed physical changes either related or not related to the MRI was recorded during and after scanning.

Secondary

MeasureTime frameDescription
Each Infant's Baseline Measurement for Weight Will be Recorded to Ensure the Infant is Less Than 6 kg.Day 1These measures will be used in order to facilitate future design of coils and transport tables for the customized MRI system.

Countries

United States

Participant flow

Pre-assignment details

The attending neonatologist determined whether the MRI scan was done with or without sedation. If possible, infants were scanned without sedation. Infants were prepared for the MRI exam by switching all monitoring devices over to MRI compatible monitors and provided with hearing protection.

Participants by arm

ArmCount
MRI for Neonates
MRI GE OPTIMA MR430s with HDX/GE Electronics: MRI scan
615
Total615

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPatients scanned on another MRI scanner35
Overall StudyPhysician Decision7

Baseline characteristics

CharacteristicMRI for Neonates
Age, Categorical
<=18 years
615 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous18.25 days
Anatomy scanned
Abdomen
7 Participants
Anatomy scanned
Brain
517 Participants
Anatomy scanned
Brain and Abdomen
2 Participants
Anatomy scanned
Brain and Chest
7 Participants
Anatomy scanned
Brain and Spine
41 Participants
Anatomy scanned
Chest
5 Participants
Anatomy scanned
Chest and Spine
1 Participants
Anatomy scanned
Orbit/Face/Neck
7 Participants
Anatomy scanned
Pelvis
1 Participants
Anatomy scanned
Pelvis and Extremity
2 Participants
Anatomy scanned
Spine
23 Participants
Anatomy scanned
Spine and Pelvis
2 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
280 Participants
Sex: Female, Male
Male
335 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 615
other
Total, other adverse events
4 / 615
serious
Total, serious adverse events
0 / 615

Outcome results

Primary

Number of Participants With Adverse Events as Observed During and After Scanning.

Any observed physical changes either related or not related to the MRI was recorded during and after scanning.

Time frame: Day 1

Population: All patients have undergone clinically indicated and ordered MRI's.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MRI for NeonatesNumber of Participants With Adverse Events as Observed During and After Scanning.4 Participants
Secondary

Each Infant's Baseline Measurement for Weight Will be Recorded to Ensure the Infant is Less Than 6 kg.

These measures will be used in order to facilitate future design of coils and transport tables for the customized MRI system.

Time frame: Day 1

Population: All patients have undergone clinically indicated and ordered MRI's.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MRI for NeonatesEach Infant's Baseline Measurement for Weight Will be Recorded to Ensure the Infant is Less Than 6 kg.615 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026